다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Creative Medical Technology Holdings Inc (CELZ)
Creative Medical Technology Holdings Inc (CELZ) 뉴스

CELZ

Creative Medical Technol... (CELZ)

Creative Medical Technology Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CELZ

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/03/27	22:00	Business Wire	Creative Medical Technology Holdings Provides Corporate Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2024/03/07	23:15	Business Wire	Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2024/03/07	06:10	AllPennyStocks.com	Biotech Finds Mid-Week Success Following FDA Announcement	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2024/03/06	21:00	Business Wire	Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/12/21	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/11/15	22:00	PR Newswire (US)	Creative Medical Technology Holdings Provides Corporate Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/11/04	05:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/10/10	21:00	PR Newswire (US)	Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/09/19	21:00	PR Newswire (US)	Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/08/12	05:45	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/30	06:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/30	06:37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/28	22:01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/28	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/28	21:00	PR Newswire (US)	Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/12	21:01	PR Newswire (US)	Creative Medical Technology Announces $2 Million Share Repurchase Program	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/12	21:00	PR Newswire (US)	Creative Medical Technology Holdings Provides Corporate Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/10	05:16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/06/10	01:30	PR Newswire (US)	Creative Medical Technology Holdings Announces Reverse Stock Split	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/31	21:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/22	21:30	PR Newswire (US)	Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz® Platform Development	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/18	21:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/13	05:32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/05/02	05:47	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/13	04:30	AllPennyStocks.com	Biotech Up Massively On Follow-Up Data	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/12	21:00	PR Newswire (US)	Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/04	21:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Filing of 2022 Form 10-K and Provides Business Update	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/04/01	05:47	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/03/23	21:00	PR Newswire (US)	Creative Medical Technology Files Orphan Drug Designation Application with the U.S. FDA Using the ImmCelz® Platform for the Treatment of Brittle Type 1 Diabetes	NASDAQ:CELZ	Creative Medical Technology Holdings Inc
2023/03/21	21:00	PR Newswire (US)	Creative Medical Technology Holdings Announces Key Milestones Regarding ImmCelz® Platform Development	NASDAQ:CELZ	Creative Medical Technology Holdings Inc

검색 관련기사 보기:NASDAQ:CELZ

1 2 3 다음 >>

Bank of America

BNP Paribas (QX)

US Dollar vs Sterling

Deutsche Telekom (QX)

US Dollar vs Yen

Gold vs US Dollar

Energy Select Sector SPDR

Financial Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관